Havens Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Havens Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-36,500	Closed	-$657K	–	31
2020 Q2	$657K	Buy	+36,500	New	+$508K	0.98%	20

Havens Advisors's PTLA Position: Q3 2020 in Review

Havens Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 36,500 shares — an estimated $657K sold.

Havens Advisors first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $657K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Havens Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Havens Advisors sold 36,500 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $657K.
Havens Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Havens Advisors's Portola Pharmaceuticals, Inc. position peaked at $657K in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Havens Advisors's 13F filing for Q3 2020, filed 8 Oct 2020.